O

    Orthofix Medical Inc (OFIX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.39
    -0.31 (-3.20%)

    Market Cap: $379.56M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    83%(33/40)
    Avg Surprise
    +78.09%
    Streak
    16 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.11
    Range$0.11 - $0.11
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.08-27.3%
    60d ago$0.05-54.5%
    30d ago$0.08-27.3%
    7d ago$0.08-27.3%
    Current$0.11
    Revenue Consensus
    $211M
    Range$210M - $211M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.62
    Range$0.62 - $0.62
    1 analysts
    Revenue Consensus
    $236M
    Range$235M - $238M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.62---
    Sep 26EST
    		-$0.11---
    Jun 26
    Reported Aug 5
    		$-0.39$-0.46+15.22%Beat-400.0%
    Mar 26
    Reported May 5
    		$-0.11N/A+62.07%Beat-266.7%
    Dec 25
    Reported Feb 24
    		$0.24$-0.22+208.09%Beat+1444.2%
    Sep 25
    Reported Nov 4
    		$0.20$0.12+66.67%Beat+185.7%
    Jun 25
    Reported Aug 5
    		$0.13$0.04+225.00%Beat+160.0%
    Mar 25
    Reported May 6
    		$-0.03N/A+88.89%Beat-127.3%
    Dec 24
    Reported Feb 25
    		$0.02N/A+130.80%Beat-48.7%
    Sep 24
    Reported Nov 7
    		$0.07N/A+146.67%Beat+0.0%
    Jun 24
    Reported Aug 6
    		$0.05N/A+126.32%Beat+150.0%
    Mar 24
    Reported May 7
    		$0.11N/A+133.33%Beat+210.0%
    Dec 23
    Reported Mar 5
    		$0.03N/A+137.50%Beat-84.2%
    Sep 23
    Reported Nov 8
    		$0.07N/A+133.33%Beat-46.2%
    Jun 23
    Reported Aug 8
    		$0.02N/A+104.26%Beat-75.0%
    Mar 23
    Reported May 9
    		$-0.10N/A+71.43%Beat+0.0%
    Dec 22
    Reported Mar 6
    		$0.19$0.10+90.00%Beat-29.6%
    Sep 22
    Reported Nov 3
    		$0.13$0.12+8.33%Beat+30.0%
    Jun 22
    Reported Aug 5
    		$0.08$0.10-20.00%Miss-75.0%
    Mar 22
    Reported May 6
    		$-0.10$0.09-211.11%Miss-158.8%
    Dec 21
    Reported Feb 25
    		$0.27$0.13+107.69%Beat-38.6%
    Sep 21
    Reported Nov 5
    		$0.10$0.09+11.11%Beat-67.7%
    Jun 21
    Reported Aug 6
    		$0.32$0.11+190.91%Beat+154.2%
    Mar 21
    Reported Apr 30
    		$0.17$0.02+750.00%Beat+88.9%
    Dec 20
    Reported Feb 26
    		$0.44$0.19+131.58%Beat-13.7%
    Sep 20
    Reported Nov 5
    		$0.31$-0.14+321.43%Beat-24.4%
    Jun 20
    Reported Aug 6
    		$-0.59$-0.75+21.33%Beat-310.7%
    Mar 20
    Reported May 8
    		$0.09$0.06+50.00%Beat-66.7%
    Dec 19
    Reported Feb 24
    		$0.51$0.58-12.07%Miss-7.3%
    Sep 19
    Reported Oct 28
    		$0.41$0.51-19.61%Miss-4.7%
    Jun 19
    Reported Aug 5
    		$0.28$0.42-33.33%Miss-33.3%
    Mar 19
    Reported May 6
    		$0.27$0.36-25.00%Miss-30.8%
    Dec 18
    Reported Feb 25
    		$0.55$0.48+14.58%Beat+5.8%
    Sep 18
    Reported Oct 29
    		$0.43$0.36+19.44%Beat+2.4%
    Jun 18
    Reported Aug 6
    		$0.42$0.36+16.67%Beat+0.0%
    Mar 18
    Reported Apr 30
    		$0.39$0.35+11.43%Beat+44.4%
    Dec 17
    Reported Feb 26
    		$0.52$0.50+4.00%Beat+23.8%
    Sep 17
    Reported Oct 30
    		$0.42$0.38+10.53%Beat+16.7%
    Jun 17
    Reported Aug 7
    		$0.42$0.37+13.51%Beat-
    Mar 17
    Reported May 4
    		$0.27$0.29-6.90%Miss-
    Dec 16
    Reported Feb 27
    		$0.42$0.37+13.51%Beat-
    Sep 16
    Reported Oct 31
    		$0.36$0.31+16.13%Beat-

    Key Metrics

    Valuation
    P/E Ratio-150.96EV/EBITDA27.55x
    Price/FCF-13.80xFCF Yield-7.24%
    Profitability
    Profit Margin-7.41%Operating Margin-3.26%
    ROE-13.90%ROIC-6.07%
    Financial Health
    Debt/Equity0.52xInterest Coverage-1.90x
    Current Ratio2.84xQuick Ratio1.67x
    Trading Statistics
    Beta0.67Avg Volume368.89K
    52-Week High$16.9952-Week Low$8.85

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$9.86
    SMA 20$10.18
    SMA 50$10.65
    SMA 200$12.40
    EMA 10$9.83
    EMA 20$10.16
    EMA 50$10.55
    EMA 200$11.90

    MACD

    Line: -0.38Signal: -0.30Hist: -0.08

    ADX

    ADX: 15.2+DI: 18.6-DI: 28.3

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$10.16

    Bollinger Bands

    Upper Band$11.34
    Lower Band$9.02
    %B Position2277%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    35.4

    Momentum Oscillators

    Stoch %K13.1
    Stoch %D16.2
    Williams %R-95.1
    ROC (10d)-6.4%
    Momentum-0.64
    CCI (20d)-137.7
    MFI (14d)37.4

    Volatility Measures

    ATR (14d)$0.46(4.9%)
    StdDev (20d)0.58
    Hist Vol58.9%(High)

    Volume Flow

    VWAP$9.44
    OBV-2.2M
    AD Line-6.2M
    CMF (20d)-0.230

    Volume Metrics

    Avg Vol (20d)366.4K
    Vol Ratio0.9x
    VWMA (20d)$10.28

    Pivot Points

    R3$10.00
    R2$9.91
    R1$9.80
    Pivot Point$9.71
    S1$9.60
    S2$9.51
    S3$9.40

    Advanced Oscillators

    TSI-19.88
    Ultimate Osc41.3
    KST-112.23

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$210.93M$196.71M$219.91M$205.63M$203.12M$193.65M$215.66M$196.61M$198.62M$188.61M$200.41M$184.01M
    Cost of Revenue$61.23M$57.16M$63.57M$57.11M$63.59M$72.03M$66.82M$61.55M$63.87M$61.37M$63.78M$64.24M
    Gross Profit$149.71M$139.55M$156.34M$148.52M$139.53M$121.62M$148.84M$135.05M$134.75M$127.24M$136.63M$119.76M
    Operating Expenses$157.84M$153.98M$155.85M$165.57M$155.54M$170.49M$160.32M$153.95M$159.66M$156.58M$154.94M$144.21M
    R&D$15.94M$15.32M$15.37M$14.77M$15.93M$19.77M$18.81M$17.29M$18.05M$19.49M$18.94M$18.56M
    SG&A$138.03M$134.91M$136.75M$148.10M$136.49M$132.98M$136.48M$130.14M$134.22M$131.69M$420.27M$27.14M
    Operating Income$-8,134,000$-14,436,000$494,000$-17,046,000$-16,003,000$-48,873,000$-11,477,000$-18,899,000$-24,906,000$-29,337,000$-18,315,000$-24,449,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$6.08M$5.66M$4.35M$4.68M$3.95M$4.51M$14.92M$5.21M$4.94M$4.56M$4.50M$1.58M
    Income Before Tax$-14,997,000$-20,834,000$-2,192,000$-22,262,000$-14,223,000$-52,133,000$-29,710,000$-26,637,000$-32,359,000$-35,169,000$-22,049,000$-28,385,000
    Income Tax Expense$801,000$74,000$30,000$533,000$-142,000$961,000$-564,000$751,000$1.08M$851,000$125,000$472,000
    Net Income$-15,798,000$-20,908,000$-2,222,000$-22,795,000$-14,081,000$-53,094,000$-29,146,000$-27,388,000$-33,443,000$-36,020,000$-22,174,000$-28,857,000
    EBITDA$5.45M$-619,000$17.21M$-3,058,000$7.72M$-11,945,000$15.55M$-1,592,000$-8,829,000$-11,224,000$6.45M$-4,604,000
    EBIT$-8,912,000$-15,170,000$2.16M$-17,581,000$-10,273,000$-47,627,000$-14,790,000$-21,427,000$-27,416,000$-30,611,000$-17,549,000$-26,809,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OFIX

    News

    Orthofix Medical (OFIX) Stock Sees Fair Value Cut After Analysts Trim Q2 Outlook

    Analysts have revised down the fair value and price targets for Orthofix Medical (OFIX) stock from US$15 to US$13, citing updated projections for revenue and cash generation, alongside the impact of the MDR transition. Despite the cuts, many analysts maintain a "Buy" or "Outperform" rating, indicating a continued constructive long-term outlook for the company, although specific factors like lower expected cash generation and weaker spine distributor performance contributed to the bearish adjustments.

    Yahoo Finance•8/24/26•
    Somewhat-Bearish

    Orthofix president Patrick Fisher sells $13,066 in stock

    Patrick Fisher, President, Global Limb Recon at Orthofix Medical Inc. (NASDAQ: OFIX), sold 1,295 shares of the company's common stock for $13,066 to cover tax withholding obligations for restricted stock units. Following the transaction, Fisher beneficially owns 51,219 shares. This sale comes as Orthofix recently surpassed Wall Street expectations for its second-quarter 2026 earnings and raised its full-year guidance.

    Investing.com•8/21/26•
    Somewhat-Bullish

    Orthofix (OFIX) insider sale tied to RSU tax withholding

    Patrick Fisher, President, Global Limb Recon at Orthofix Medical Inc. (OFIX), sold 1,295 shares of common stock at $10.09 per share on August 18, 2026. This sale was a mandatory "sell-to-cover" transaction to satisfy tax withholding obligations related to restricted stock units and was not discretionary. Following the sale, Fisher directly holds 51,219 shares, including restricted stock units and shares acquired through Orthofix’s Stock Purchase Plan.

    Stock Titan•8/20/26•
    Neutral

    Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com

    Juniper Investment Company, LLC, a 10% owner and director of Orthofix Medical Inc. (NASDAQ:OFIX), recently sold $402,744 worth of the company's common stock in August 2026. Despite the sales and a year-to-date stock decline, InvestingPro analysis suggests Orthofix Medical is undervalued, with analysts forecasting profitability in the coming year. These transactions occurred across two dates, with shares sold at weighted average prices of $10.3838 and $10.013.

    Investing.com•8/19/26•
    Somewhat-Bullish

    Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com

    Juniper Investment Company, a 10% owner and director of Orthofix Medical Inc. (NASDAQ:OFIX), sold 39,500 shares totaling $402,744 in two August 2026 transactions. Despite the sales and a 33% year-to-date stock decline, InvestingPro analysis suggests OFIX is undervalued, with analysts forecasting profitability for the current year. Juniper Investment Company retains significant holdings in Orthofix Medical through various funds.

    Investing.com•8/18/26•
    Neutral

    Frequently Asked Questions About OFIX

    Does OFIX pay dividends?
    Orthofix Medical Inc (OFIX) does not currently pay a regular dividend.
    What is OFIX's market cap?
    Orthofix Medical Inc (OFIX) has a market capitalization of $379.56M with a current stock price of $9.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In